<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Chin Med J (Engl)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Chin. Med. J</journal-id>
      <journal-id journal-id-type="publisher-id">CMJ</journal-id>
      <journal-title-group>
        <journal-title>Chinese Medical Journal</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0366-6999</issn>
      <publisher>
        <publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name>
        <publisher-loc>India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26612306</article-id>
      <article-id pub-id-type="pmc">4794870</article-id>
      <article-id pub-id-type="publisher-id">CMJ-128-3256</article-id>
      <article-id pub-id-type="doi">10.4103/0366-6999.170276</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Clinical Practice</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Lymphoma without Lymphadenopathy</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Jain</surname>
            <given-names>Ashutosh</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kumar</surname>
            <given-names>Nilesh</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jangid</surname>
            <given-names>Mahendra K</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gambhir</surname>
            <given-names>Indrajeet Singh</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tilak</surname>
            <given-names>Vijai</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Department of General Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India</aff>
      <aff id="aff2"><label>2</label>Department of General Medicine, Division of Geriatrics, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India</aff>
      <aff id="aff3"><label>3</label>Department of Pathology, Division of Hematology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India</aff>
      <author-notes>
        <corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Ashutosh Jain, 02, Dhanwantari Hostel, BHU, Varanasi - 221 005, Uttar Pradesh, India E-Mail: <email xlink:href="ashu.ims07@gmail.com">ashu.ims07@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>05</day>
        <month>12</month>
        <year>2015</year>
      </pub-date>
      <volume>128</volume>
      <issue>23</issue>
      <fpage>3256</fpage>
      <lpage>3257</lpage>
      <history>
        <date date-type="received">
          <day>14</day>
          <month>4</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright: &#xA9; 2015 Chinese Medical Journal</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p>
        </license>
      </permissions>
      <kwd-group>
        <kwd>Chronic Lymphocytic Leukemia</kwd>
        <kwd>Cyclin D1</kwd>
        <kwd>Lymphadenopathy</kwd>
        <kwd>Mantle Cell Lymphoma</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>A seventy-five years old man was presented to our hospital with a complaint of gradually progressive heaviness in the left half of abdomen for past 10 months. History was negative for fever, weight loss, and night sweats. Physical examination was noteworthy for moderate pallor and massive splenomegaly [<xref ref-type="fig" rid="F1">Figure 1a</xref>].</p>
    <fig id="F1" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Splenic area marked (a); Peripheral blood film (b); Ultrasonography showing splenomegaly (c).</p>
      </caption>
      <graphic xlink:href="CMJ-128-3256-g001"/>
    </fig>
    <p>There was no lymphadenopathy. Routine investigations showed: Hemoglobin 70 g/L, total leucocyte count: 98.4 &#xD7; 10<sup>9</sup>/L, neutrophils: 4%, lymphocytes: 93%, monocytes: 2%, and platelet count: 103 &#xD7; 10<sup>9</sup>/L. Peripheral blood smear showed markedly increased the number of leukocytes with a fair number of smudged cells. Red blood cells showed anisopoikilocytosis with the predominantly normocytic normochromic picture [<xref ref-type="fig" rid="F1">Figure 1b</xref>].</p>
    <p>Platelets were reduced in number to 103 &#xD7; 10<sup>9</sup>/L. Renal and liver function tests, serum lactate dehydrogenase (298 U/L), serum uric acid levels (6.5 mg/dl), chest X-ray, and electrocardiogram were within normal limits. Coomb's test was negative, and stool analysis was negative for occult blood. The ultrasonography of abdomen showed gross splenomegaly [<xref ref-type="fig" rid="F1">Figure 1c</xref>]. Contrast-enhanced computed tomography (CT) of chest and abdomen confirmed splenomegaly and did not reveal additional information. However, positron emission tomography-CT imaging was not performed.</p>
    <p>Conventional karyotyping was normal. The patient did not give consent for splenic aspiration. Bone marrow aspiration and biopsy revealed diffuse infiltrates of small lymphoid cells with nuclear round contour and scanty cytoplasm, suggestive of chronic lymphocytic leukemia (CLL) [<xref ref-type="fig" rid="F2">Figure 2a</xref>]. Immunophenotyping by flow cytometry revealed: CD79b (77.1%) was strongly positive, CD5 (98.1% of gated lymphocytes), and CD23 (51.1%) were positive. FMC-7 was positive (51.1%), and surface immunoglobulin (1.7%) was negative. Immunophenotyping results were disfavoring CLL/small lymphocytic lymphoma (CLL/SLL) as according to the scoring system, a score of 4 or 5 is required for the diagnosis of CLL, whereas here the score was 3.</p>
    <fig id="F2" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Bone marrow trephine biopsy (a); Fluorescence <italic>in situ</italic> hybridization was done, and it was positive for IgH/CCND1 fusion signal (b)</p>
      </caption>
      <graphic xlink:href="CMJ-128-3256-g002"/>
    </fig>
    <p>Typically, CLL cells express weak monotypic surface immunoglobulin, CD5, CD19, CD23 and weak or absent CD79B, CD22, and FMC7. Using a recommended panel of scoring system for the diagnosis of CLL.[<xref rid="ref1" ref-type="bibr">1</xref>] Ninety-two percent of CLL cases score 4 or 5, 6% score 3, and 2% score 1 or 2. Most other chronic B-cell lymphomas and leukemias score 1 or 2, but a minority score 3. Scores in CLL are usually &gt;3, in other B-cell malignancies the scores are usually &lt;3.</p>
    <p>The scatter parameters and antigen expression profile as studied by flow cytometry of the sample were suggestive of atypical chronic lymphocytic leukemia, B-CLL. No single type of lymphoma/leukemia was matching with clinical and flow cytmetry parameters.</p>
    <p>In spite of the absence of lymphadenopathy, presence of massive splenomegaly and lack of &#x201C;CD23 negativity&#x201D; mantle cell lymphoma (MCL) was a possibility before labeling it as atypical B-cell CLL, as there are case reports of MCL without lymphadenopathy and with CD23 positivity, but the combination of all three parameters (absence of lymphadenopathy, presence of massive splenomegaly, and CD23 positivity) were making possibility of MCL dubious. But flow cytometry results prompted us to pursue the diagnosis of MCL as it was the only other plausibility apart from CLL, for which flow results were least unfavorable.</p>
    <p>Fluorescence <italic>in situ</italic> hybridization (FISH) was done, and it was positive for IgH/CCND1 fusion signal. IgH/CCND1 fusion signal was detected in 92% cells by FISH [<xref ref-type="fig" rid="F2">Figure 2b</xref>].</p>
    <p>MCL is one of the several subtypes of B-cell non-Hodgkin lymphoma. The distinction between SLL/CLL and MCL has important clinical implications. Typically, SLL/CLL is CD23+, whereas MCL is CD23&#x2212;. The majority of MCL cases co-express CD20, CD5, BCL2, and cyclin D1. MCL is usually negative for CD10, BCL6 and CD23. Chromosomal translocation characteristic for MCL is t(11;14)(q13;q32), which results in overexpression of the cell cycle protein cyclin D1.[<xref rid="ref2" ref-type="bibr">2</xref>]</p>
    <p>In reports that include CD23+ MCL cases, detected by flow cytometric or immunohistochemical analysis, the frequency of CD23 expression has ranged from 2% to 45%. MCL is an aggressive lymphoma with moderate chemosensitivity. Reliably curative treatments for MCL are lacking. An inexorable pattern of progression is characteristic, with a median time to treatment failure of &lt;18 months.[<xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref4" ref-type="bibr">4</xref>]</p>
    <p>The absence of lymphadenopathy and presence of CD23 positivity makes this case a rare one among all MCL cases. This patient was started on bendamustine rituximab chemoregimen for 6 cycles, and he showed partial remission after completion of the forth cycle.</p>
    <sec disp-level="2" id="sec2-1">
      <title>Financial support and sponsorship</title>
      <p>Nil.</p>
    </sec>
    <sec disp-level="2" id="sec2-2">
      <title>Conflicts of interest</title>
      <p>There are no conflicts of interest.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="edited-by">
        <p><bold>Edited by:</bold> Yi Cui</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>R<sc>EFERENCES</sc></title>
      <ref id="ref1">
        <label>1</label>
        <nlm-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moreau</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Matutes</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>A&#x2019;Hern</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Morilla</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Morilla</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Owusu-Ankomah</surname>
              <given-names>KA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b)</article-title>
          <source>Am J Clin Pathol</source>
          <year>1997</year>
          <volume>108</volume>
          <fpage>378</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="pmid">9322589</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <nlm-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Swerdlow</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Berger</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Isaacson</surname>
              <given-names>PI</given-names>
            </name>
            <name>
              <surname>Muller-Hermelink</surname>
              <given-names>HK</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Jaffe</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>NL</given-names>
            </name>
            <name>
              <surname>Stein</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Vardiman</surname>
              <given-names>JW</given-names>
            </name>
          </person-group>
          <article-title>Mantle cell lymphoma</article-title>
          <source>Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues</source>
          <year>2001</year>
          <publisher-loc>Lyon, France</publisher-loc>
          <publisher-name>IARC Press</publisher-name>
          <fpage>168</fpage>
          <lpage>70</lpage>
        </nlm-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <nlm-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McKay</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Leach</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jackson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Cook</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Rule</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>British Committee for Standards in Haematology. Guidelines for the investigation and management of mantle cell lymphoma</article-title>
          <source>Br J Haematol</source>
          <year>2012</year>
          <volume>159</volume>
          <fpage>405</fpage>
          <lpage>26</lpage>
          <pub-id pub-id-type="pmid">22994971</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <nlm-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oscier</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Fegan</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hillmen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Illidge</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Maguire</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Guidelines on the diagnosis and management of chronic lymphocytic leukaemia</article-title>
          <source>Br J Haematol</source>
          <year>2004</year>
          <volume>125</volume>
          <fpage>294</fpage>
          <lpage>317</lpage>
          <pub-id pub-id-type="pmid">15086411</pub-id>
        </nlm-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
